These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 20432790

  • 1. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C, Tudorache V, Oancea C.
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [Abstract] [Full Text] [Related]

  • 2. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB.
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
    Bułdak Ł, Duława A, Krysiak R, Okopień B.
    Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
    [Abstract] [Full Text] [Related]

  • 8. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 9. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH.
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [Abstract] [Full Text] [Related]

  • 10. Use of beta-blockers in patients with COPD.
    Andrus MR, Holloway KP, Clark DB.
    Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH, Padeletti M, Jelic S.
    J Am Coll Cardiol; 2007 Jan 16; 49(2):171-80. PubMed ID: 17222727
    [Abstract] [Full Text] [Related]

  • 12. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.
    Au DH, Bryson CL, Fan VS, Udris EM, Curtis JR, McDonell MB, Fihn SD.
    Am J Med; 2004 Dec 15; 117(12):925-31. PubMed ID: 15629731
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA, Schumock GT, Bartle B, Pickard AS.
    Pharmacotherapy; 2009 Sep 15; 29(9):1039-53. PubMed ID: 19698009
    [Abstract] [Full Text] [Related]

  • 20. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
    van Gestel YR, Hoeks SE, Sin DD, Welten GM, Schouten O, Witteveen HJ, Simsek C, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D.
    Am J Respir Crit Care Med; 2008 Oct 01; 178(7):695-700. PubMed ID: 18565952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.